White label ELPA - ClinicalTrials.eu

Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

Recruiting

2 1 1 1
Investigated diseases:
- Attention deficit hyperactivity disorder
- Type 1 diabetes mellitus
Investigated drugs:
- Lisdexamfetamine Dimesylate
- Methylphenidate Hydrochloride
Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

Recruiting

3 1 1 1
Investigated diseases:
- Short-bowel syndrome
Investigated drugs:
- Rivaroxaban
Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

Recruiting

3 1 1 1
Investigated diseases:
- Nervous system disorder
Investigated drugs:
- Ocrelizumab
Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

Recruiting

3 1 1 1
Investigated diseases:
- Intracranial aneurysm
Investigated drugs:
- Dipyridamole
- Acetylsalicylic Acid
Study on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)

Recruiting

3 1 1 1
Investigated diseases:
- Systemic lupus erythematosus
Investigated drugs:
- Obinutuzumab
- Rituximab
Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

Recruiting

3 1 1 1
Investigated diseases:
- Inflammatory bowel disease
- Rheumatic disorder
Investigated drugs:
Study on Indocyanine Green for Evaluating Blood Flow in Surgery for Women with Recurrent or Persistent Gynecological Cancer

Recruiting

2 1 1 1
Investigated drugs:
- Indocyanine Green
Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Cemiplimab
- Fianlimab
Study on the Effect of Lutropin Alfa to Improve Ovarian Reserve in Patients Undergoing IVF/ICSI Due to Tubal, Male Factor, or Unexplained Infertility

Recruiting

2 1 1 1
Investigated drugs:
- Lutropin Alfa
Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

Recruiting

2 1 1 1
Investigated diseases:
- Squamous cell carcinoma of skin
Investigated drugs:
- Cemiplimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies